Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 8:12:32.
doi: 10.1186/1476-511X-12-32.

MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα

Affiliations

MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα

Dan Zhong et al. Lipids Health Dis. .

Abstract

Background: MicroRNAs (miRNAs) emerge as new important regulators of lipid homeostasis by regulating corresponding genes. MiR-613 is a newly discovered microRNA, of which the biological function is unknown. A recent report has shown that miR-613 downregulates liver X receptor α (LXRα), a ligand-activated nuclear receptor playing an important role in the regulation of lipid metabolism. The purpose of this study is to explore the effect and the molecular basis of miR-613 on lipogenesis in HepG2 cells.

Methods: HepG2 cells were transiently transfected with miR-613 mimic or control microRNA. Real time PCR, Western blot, Luciferase reporter assay and Oil Red O staining were employed to examine the expression of LXRα and its target genes involved in lipogenesis, binding site for miR-613 in 3'-untranslated region (3'-UTR) of LXRα mRNA and lipid droplet accumulation in the cells.

Results: MiR-613 dramatically suppressed the expression of LXRα and its target genes including sterol-regulatory element binding protein 1c (SREBP-1c), fatty acid synthase (FAS), carbohydrate responsive element-binding protein (ChREBP) and acetyl-CoA carboxylase (ACC). Reporter assay showed that miR-613 directly bound to 3'-UTR of LXRα mRNA. Moreover, miR-613 significantly repressed LXRα-induced lipid droplet accumulation in HepG2 cells. Ectopic expression of LXRα without 3'-UTR markedly attenuated the miR-613-mediated downregulation of LXRα's target genes and LXRα-induced lipid droplet accumulation.

Conclusions: MiR-613 suppresses lipogenesis by directly targeting LXRα in HepG2 cells, suggesting that miR-613 may serve as a novel target for regulating lipid homeostasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MiR-613 decreases LXRα expression at both mRNA and protein levels. A: HepG2 cells were transfected with 80 nM miR-613 mimic or mimic negative control (NC), after 24 hours total protein was subjected to Western blotting analysis and mRNA expression levels of LXRα were analyzed by real-time quantitative PCR and normalized with β-actin control. B and D, HepG2 cells were treated with TO901317 (5 μM) or GW3965 (2 μM) for 24 hours. Western blot analysis for LXRα protein level (B) and Real-time PCR analysis for LXRα mRNA level (D). C and E, 12 hours after transfected with 80 nM miR-613 mimic or NC, HepG2 cells were treated with TO901317 (5 μM) or GW3965 (2 μM) for 24 hours. Western blot analysis for LXRα protein level (C) and Real-time PCR analysis for LXRα mRNA level (E). The relative level of LXRα expression determined using the 2-△△CT method. *, P < 0.05 (n = 3 for each group).
Figure 2
Figure 2
MiR-613 directly targets LXRα 3-UTR. A: A putative binding site of miR-613 in the 3-UTR of LXRα mRNA and mutated nucleotide residues are shown in red and italics. B: pMIR/LXRαMIRE or pMIR/LXRαMIRE-mut was cotransfected with 80 nM miR-613 mimic or NC into HepG2 cells. C, pMIR-LXRβ was transiently cotransfected with 80 nM indicated RNA oligonucleotides into HepG2 cells. Luciferase assay was conducted after 24 hours. The data was the firefly luciferase activities normalized with the β-galactosidase activities. *, P < 0.05 (n = 3 for each group).
Figure 3
Figure 3
MiR-613 suppresses LXRα-induced lipogenic genes. A and B: HepG2 cells were treated with TO901317 (5 μM) or GW3965 (2 μM) for 24 hours. Real-time PCR analysis for SREBP-1c, FAS, ChREBP and ACC mRNA level. C and D, after 12 hours transfected with 80 nM miR-613 mimic or NC, HepG2 cells were treated with TO901317 (5 μM) or GW3965 (2 μM) for 24 hours. Real-time PCR analysis for SREBP-1c, FAS, ChREBP and ACC mRNA level. The relative level of lipogenic gene expression determined using the 2-△△CT method. *, P < 0.05 (n = 3 for each group).
Figure 4
Figure 4
MiR-613 represses lipogenic genes by mediating LXRα. HepG2 cells were cotransfected with 80 nM miR-613 mimic or NC and LXRα-expressing plasmid pEX-LXRα (without 3-UTR in LXRα mRNA) for 24 hours. The SREBP-1c, FAS, ChREBP and ACC expression was normalized to β-actin mRNA expression, respectively. The relative level of indicated gene expression determined using the 2-△△CT method. *, P<0.05 (n=3 for each group).
Figure 5
Figure 5
MiR-613 represses lipogenesis by mediating LXRα. The lipid synthesis was shown by Oil Red O staining (400×). A: After 12 hours transfected with 80 nM miR-613 mimic or NC, HepG2 cells were treated with TO901317 (5 μM) or GW3965 (2 μM) for 24 hours. B: HepG2 cells were cotransfected with 80 nM miR-613 mimic or NC and LXRα-expressing plasmid pEX-LXRα for 24 hours. Results represent 3 independent experiments.

Similar articles

Cited by

References

    1. Fernandez-Valverde SL, Taft RJ, Mattick JS. MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications. Diabetes. 2011;60(7):1825–1831. doi: 10.2337/db11-0171. - DOI - PMC - PubMed
    1. David S, Meltzer SJ. MicroRNA involvement in esophageal carcinogenesis. Curr Opin Pharmacol. 2011;11(6):612–616. doi: 10.1016/j.coph.2011.09.006. - DOI - PMC - PubMed
    1. Zhang C. MicroRNA and vascular smooth muscle cell phenotype: new therapy for atherosclerosis? Genome Med. 2009;1(9):85. doi: 10.1186/gm85. - DOI - PMC - PubMed
    1. Sacco J, Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol. 2012;23(3):220–225. doi: 10.1097/MOL.0b013e3283534c9f. - DOI - PubMed
    1. Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol. 2011;22(2):86–92. doi: 10.1097/MOL.0b013e3283428d9d. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources